Zhou X - Search Results

1

Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.

Fan Y, Zhou X, Xia TS, Chen Z, Li J, Liu Q, Alolga RN, Chen Y, Lai MD, Li P, Zhu W, Qi LW. Fan Y, et al. Among authors: zhou x. Oncotarget. 2016 Mar 1;7(9):9925-38. doi: 10.18632/oncotarget.7155. Oncotarget. 2016. PMID: 26848530 Free PMC article.

2

Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.

Huang Z, Wu Y, Zhou X, Qian J, Zhu W, Shu Y, Liu P. Huang Z, et al. Among authors: zhou x. Future Oncol. 2015;11(11):1687-99. doi: 10.2217/fon.15.70. Future Oncol. 2015. PMID: 26043220 Review.

3

Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis.

Zhou X, Zhu W, Li H, Wen W, Cheng W, Wang F, Wu Y, Qi L, Fan Y, Chen Y, Ding Y, Xu J, Qian J, Huang Z, Wang T, Zhu D, Shu Y, Liu P. Zhou X, et al. Sci Rep. 2015 Jun 10;5:11251. doi: 10.1038/srep11251. Sci Rep. 2015. PMID: 26059512 Free PMC article.

4

miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.

Du Y, Zhu M, Zhou X, Huang Z, Zhu J, Xu J, Cheng G, Shu Y, Liu P, Zhu W, Wang T. Du Y, et al. Among authors: zhou x. Tumour Biol. 2016 Jan;37(1):1261-9. doi: 10.1007/s13277-015-3921-1. Epub 2015 Aug 20. Tumour Biol. 2016. PMID: 26286834

5

MiR-4728-3p could act as a marker of HER2 status.

Li H, Zhou X, Zhu J, Cheng W, Zhu W, Shu Y, Liu P. Li H, et al. Among authors: zhou x. Cancer Biomark. 2015;15(6):807-14. doi: 10.3233/CBM-150524. Cancer Biomark. 2015. PMID: 26406406

6

MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism.

Zhou X, Wen W, Shan X, Qian J, Li H, Jiang T, Wang W, Cheng W, Wang F, Qi L, Ding Y, Liu P, Zhu W, Chen Y. Zhou X, et al. Thromb Res. 2016 Feb;138:91-95. doi: 10.1016/j.thromres.2015.12.006. Epub 2015 Dec 10. Thromb Res. 2016. PMID: 26702486

7

Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.

Zou M, Wang F, Gao R, Wu J, Ou Y, Chen X, Wang T, Zhou X, Zhu W, Li P, Qi LW, Jiang T, Wang W, Li C, Chen J, He Q, Chen Y. Zou M, et al. Among authors: zhou x. Sci Rep. 2016 Apr 21;6:24747. doi: 10.1038/srep24747. Sci Rep. 2016. PMID: 27098600 Free PMC article.

8

miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.

Zhu M, Zhou X, Du Y, Huang Z, Zhu J, Xu J, Cheng G, Shu Y, Liu P, Zhu W, Wang T. Zhu M, et al. Among authors: zhou x. Mol Med Rep. 2016 Aug;14(2):1742-50. doi: 10.3892/mmr.2016.5413. Epub 2016 Jun 21. Mol Med Rep. 2016. PMID: 27357419

9

The hematologic markers as prognostic factors in patients with resectable gastric cancer.

Zhou X, Xu L, Huang Z, Zhang L, Zhang H, Zhu W, Liu P. Zhou X, et al. Cancer Biomark. 2016 Sep 26;17(3):359-367. doi: 10.3233/CBM-160648. Cancer Biomark. 2016. PMID: 27434296

10

MicroRNA-3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip-α, by targeting TRAF3.

Zou M, Wang F, Jiang A, Xia A, Kong S, Gong C, Zhu M, Zhou X, Zhu J, Zhu W, Cheng W. Zou M, et al. Among authors: zhou x. Helicobacter. 2017 Apr;22(2). doi: 10.1111/hel.12348. Epub 2016 Aug 5. Helicobacter. 2017. PMID: 27493095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,379 results

Search Page

Filters